Please login to the form below
Orfadin
This page shows the latest Orfadin news and features for those working in and with pharma, biotech and healthcare.
Orphan drug firm Sobi opens new European base
In July the European Commission approved an oral suspension formulation of Orfadin (nitisinone), which treats the rare - and potentially fatal - genetic disease Hereditary Tyrosinaemia type-1 (HT-1). ... More recently the FDA this week began its review
Latest news
-
Sobi wins European approval for oral form of orphan drug Orfadin
Expandstreatment options for rare genetic disease HT-1. The European Commission has approved an oral suspension formulation of Swedish Orphan Biovitrum's (Sobi) Orfadin (nitisinone). ... An oral suspension of Orfadin for paediatric use will facilitate
-
PatientsLikeMe takes aim at one of world's rarest diseases
disease. Although there is currently no cure for AKU, Swedish Orphan Biovitrum's tyrosinaemia treatment Orfadin (nitisinone) is used off-label to treat AKU and is expected to enter phase III
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Account Director
-
£48, 000 - £60, 000
-
Associate Director
-
£75, 000-90, 000
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Medical Writers
-
Competitive Salary and Benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Senior Account Manager
-
Negotiable
-
Medical/ Scientific Director
-
Salary TBC
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Senior Systematic Review Analyst - Oxford
-
Negotiable
Subscribe to our email news alerts
- Herpes Labialis Treatment Market is anticipated to expand at a CAGR of 4.6% over 2017-2027
- Molecular Biology Enzymes, Kits & Reagents Market worldwide are poised to exceed US$ 21,000 Mn in revenues by 2026-end.
- Anaesthesia Machines Market: A Billion Dollar Increase in Sales Revenue During 2017 - 2027
- Female Pelvic Implants Market is expected to reach a value of over US$ 300 Mn by the end of 2027
- Vulvodynia Treatment Market is expected to register a CAGR of 6.1% over the forecast period of 2018 and 2028
- 3D Printed Medical Devices Market is expected to expand at a CAGR of 18.1% during the forecast period 2017–2027
PMHub
Complete Medical Communications (CMC)
CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...
Latest intelligence
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
Quick links
Infographics
